IVABRADINE HCL
SELECTIVE I(F) CURRENT INHIBITORS - SA NODE · CHRONIC HEART FAILURE
NORTHSTAR RX LL
Drug class
Selective I(f) Current Inhibitors - SA Node
Selective I(f) current inhibitors of the sinoatrial (SA) node—predominantly classified in regulatory pharmacology as hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers—are cardiovascular agents that slow cardiac pacemaker automaticity. Read more about Selective I(f) Current Inhibitors - SA Node
10 drugs in this class 10 manufacturers
Drugs in Selective I(f) Current Inhibitors - SA Node
Filter & compare in the drug finder →
Opens the drug finder with Selective I(f) Current Inhibitors - SA Node preselected. Add indication or manufacturer filters there.
Selective I(f) current inhibitors of the sinoatrial (SA) node—predominantly classified in regulatory pharmacology as hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers—are cardiovascular agents that slow cardiac pacemaker automaticity.
They act by selectively inhibiting the mixed inward sodium-potassium hyperpolarization-activated funny current (I(f)) within SA node pacemaker cells, which prolongs diastolic depolarization and lowers heart rate without impairing ventricular repolarization, myocardial contractility, or vascular tone.
Clinically exemplified by ivabradine, this class is utilized to reduce hospitalizations in patients with stable, symptomatic chronic heart failure with reduced ejection fraction and elevated resting sinus rhythm, and it is also established internationally for the management of chronic stable angina pectoris.
-
fda.gov
Selective I(f) current inhibitors of the sinoatrial (SA) node—predominantly classified in regulatory pharmacology as hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers—are cardiovascular agents that slow cardiac pacemaker automaticity They act by selectively inhibiting the mixed inward sodium-potassium hyperpolarization-activated funny current (I(f)) within SA node pacemaker cells, which prolongs diastolic depolarization and lowers heart rate without impairing ventricular...
-
fda.gov
Selective I(f) current inhibitors of the sinoatrial (SA) node—predominantly classified in regulatory pharmacology as hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers—are cardiovascular agents that slow cardiac pacemaker automaticity
-
rxlist.com
They act by selectively inhibiting the mixed inward sodium-potassium hyperpolarization-activated funny current (I(f)) within SA node pacemaker cells, which prolongs diastolic depolarization and lowers heart rate without impairing ventricular repolarization, myocardial contractility, or vascular tone
-
researchgate.net
They act by selectively inhibiting the mixed inward sodium-potassium hyperpolarization-activated funny current (I(f)) within SA node pacemaker cells, which prolongs diastolic depolarization and lowers heart rate without impairing ventricular repolarization, myocardial contractility, or vascular tone
-
patsnap.com
Clinically exemplified by ivabradine, this class is utilized to reduce hospitalizations in patients with stable, symptomatic chronic heart failure with reduced ejection fraction and elevated resting sinus rhythm, and it is also established internationally for the management of chronic stable angina pectoris
-
wa.gov
Clinically exemplified by ivabradine, this class is utilized to reduce hospitalizations in patients with stable, symptomatic chronic heart failure with reduced ejection fraction and elevated resting sinus rhythm, and it is also established internationally for the management of chronic stable angina pectoris
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.